Kiniksa Pharmaceuticals International Plc (KNSA)
46.00
+1.51
(+3.39%)
USD |
NASDAQ |
Mar 02, 16:00
45.96
-0.04
(-0.09%)
Pre-Market: 08:14
Kiniksa Pharmaceuticals International Research and Development Expense (TTM) : 96.66M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Marker Therapeutics, Inc. | 14.74M |
| NovoCure Ltd. | 224.54M |
| LivaNova Plc | 185.14M |
| Alterola Biotech, Inc. | -- |
| Akanda Corp. | -- |